Target intelligence / Profile preview

cAMP-dependent protein kinase type I-alpha regulatory subunit mRNA (PRKAR1A mRNA)

Target
PRKAR1A mRNA
01

Overview

The query "mRNA of Protein Kinase A regulatory subunit I alpha" refers specifically to the messenger RNA (mRNA) transcript that encodes the **cAMP-dependent protein kinase type I-alpha regulatory subunit** (gene symbol: PRKAR1A). While the mRNA is essential for the expression of the PRKAR1A protein, which functions as the regulatory subunit of type I protein kinase A (PKA), *mRNA itself is not considered a direct therapeutic target* in the same sense as receptors, enzymes, or protein complexes[4][5]. Rather, research and clinical focus relate to the PRKAR1A protein product, not its mRNA—except in the context of genetic tests, gene expression studies, or RNA-targeting therapeutics. If your intention is to retrieve structured information about a therapeutic protein target, the correct target should be the **PRKAR1A protein** (the protein product of the mRNA)[5][7][8].\n\n**Clarification:** \n- The PRKAR1A mRNA is the transcript, not the druggable protein. \n- The appropriate canonical form for a therapeutic target is "cAMP-dependent protein kinase type I-alpha regulatory subunit" or "PRKAR1A" (for the protein), not its mRNA[5][8].\n- Please clarify if you are interested in RNA interference, antisense, or other RNA-targeting modalities that may treat the mRNA as a drug target, which is rare and very specific.\n\n**Summary of Correct Entity for Target Assessment:** \n- The **PRKAR1A gene** encodes the regulatory subunit type I-alpha of protein kinase A, a critical modulator of cAMP signaling, with known roles in endocrine tumor syndromes (e.g., Carney complex) and potentially other diseases[4][5][7]. \n- The **PRKAR1A protein** is a validated molecular target with therapeutic and biomarker relevance. \n- The **mRNA** is not conventionally classified as a therapeutic target except in specialized gene-targeted therapies.\n\n**Recommendation:** \n- Use "cAMP-dependent protein kinase type I-alpha regulatory subunit" (PRKAR1A) as the canonical target for drug discovery, therapeutic, or biomarker purposes[5][8].\n- Use "PRKAR1A mRNA" only for gene expression, RNA biology, or RNA-targeting therapeutic queries.

Other names
PRKAR1A mRNAmRNA of protein kinase A regulatory subunit I alpha

Beyond the preview

Go deeper on cAMP-dependent protein kinase type I-alpha regulatory subunit mRNA (PRKAR1A mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cAMP-dependent protein kinase type I-alpha regulatory subunit mRNA (PRKAR1A mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call